(Research Report) 2016 Public Opinion Survey on Healthcare Policy
date : 12/1/2016
![(Research Report) 2016 Public Opinion Survey on Healthcare Policy](https://hgpi.org/en/wp-content/uploads/sites/2/6773362af927d0fa452e5f29a9b623c0.png)
HGPI has been undertaking regular surveys of public opinions on healthcare issues since 2006 in order to gain a better understanding of public perceptions and awareness on the health and health care policies the public desires.
Continuing on from previous surveys, the 2016 survey included questions on the level of satisfaction with the current healthcare system and the degree of trust in healthcare personnel and organizations. In addition, there were also questions on hot topics such as high priced drugs and medical practices.
Summary of survey results
- 70% are in favor of the use of insurance to pay for high priced drugs; however, many people also expressed the opinion that some form of restriction should be put in place
- The degree of trust towards pharmacists has reached 83% for a wide range of age groups, which is the highest rate among healthcare professionals
- Improving trust towards the Government – the degree of trust towards the Ministry of Health, Labour, and Welfare increased by 15 points
Healthcare policy derived from survey results
This survey produced the following points of discussion related to healthcare sustainability.
- How can we aim for full participation by citizens in the healthcare decision making process and help citizens understand cost sharing structures?
- How can we strike a balance between the use of insurance and limited public funds to pay for the new drugs and medical treatments developed through technological advances?
For more detailed information on the survey, please refer to the PDF.
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)